On October 23, Gelunhui | Janux Therapeutics (JANX.US) rose 4% before the market opened to $54.9. According to the documents disclosed by the Securities and Exchange Commission (SEC) on October 22, Director RA CAPITAL MANAGEMENT, L.P. of Janux Therapeutics increased its shareholding by 1.2 million shares of common stock at an average price of $44.75 per share on October 18, with a value of approximately $53.7 million. (Gelonghui)
美股异动丨Janux Therapeutics盘前涨4% 获董事增持超5千万美元
US stocks anomaly | Janux Therapeutics rose 4% before the market, with directors acquiring over 50 million US dollars in shareholding.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated